Xu Jia-Nan, Chen Jian-Ping, Chen Da-Li
Department of Parasitology and Microbiology, West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu, China.
Clin Vaccine Immunol. 2012 Apr;19(4):536-44. doi: 10.1128/CVI.05708-11. Epub 2012 Feb 22.
In order to identify immunodominant antigens of Mycobacterium tuberculosis that may be used in the serodiagnosis of active tuberculosis (TB), we designed an M. tuberculosis fusion protein consisting of CFP-10 (10-kDa culture filtrate protein), ESAT-6 (6-kDa early secreted antigenic target), and the extracellular domain fragment of PPE68 (PPE68'). Then, the coding sequences of the three proteins were inserted into a prokaryotic expression vector, pET-32a(+). To enhance the immunological response, the proteins were linked together. The fusion proteins with a 6 × His tag were successfully overexpressed in Escherichia coli BL21 and purified. The purified proteins were applied for detection of the total IgG titer by using an enzyme-linked immunosorbent assay (ELISA) with human sera from well-characterized TB cases and the control cases, and results were compared to those with purified protein derivative tuberculin (PPD). The ELISA results showed that among 140 cases of confirmed active TB and 70 control cases, CFP-10-ESAT-6-PPE68' had a sensitivity of 73.3% and specificity of 94.3%, compared to a sensitivity of 66.7% and specificity of 74.3% for PPD and a sensitivity of 65% and specificity of 91.4% for CFP-10-ESAT-6. In addition, the fusion protein CFP-10-ESAT-6-PPE68' stimulated a higher level of antigen-specific gamma interferon (IFN-γ) release for active-TB patients than PPD and CFP-10-ESAT-6. After immunization of C57BL/6 mice, the findings indicated that the total IgG titers and the concentrations of IFN-γ in mice immunized by CFP-10-ESAT-6-PPE68' were high and induced strong, long-term humoral immunity compared to results with PPD and CFP-10-ESAT-6. Thus, our study indicates that the fusion protein CFP-10-ESAT-6-PPE68' may be useful as an immunodominant antigen for the serodiagnosis of active TB.
为了鉴定可用于活动性肺结核(TB)血清诊断的结核分枝杆菌免疫显性抗原,我们设计了一种由CFP-10(10 kDa培养滤液蛋白)、ESAT-6(6 kDa早期分泌抗原靶点)和PPE68细胞外结构域片段(PPE68')组成的结核分枝杆菌融合蛋白。然后,将这三种蛋白的编码序列插入原核表达载体pET-32a(+)中。为增强免疫反应,将这些蛋白连接在一起。带有6×His标签的融合蛋白在大肠杆菌BL21中成功过表达并纯化。使用酶联免疫吸附测定(ELISA),将纯化后的蛋白用于检测来自明确诊断的TB病例和对照病例的人血清中的总IgG滴度,并将结果与纯化蛋白衍生物结核菌素(PPD)的结果进行比较。ELISA结果显示,在140例确诊的活动性TB病例和70例对照病例中,CFP-10-ESAT-6-PPE68'的敏感性为73.3%,特异性为94.3%,而PPD的敏感性为66.7%,特异性为74.3%,CFP-10-ESAT-6的敏感性为65%,特异性为91.4%。此外,融合蛋白CFP-10-ESAT-6-PPE68'刺激活动性TB患者释放的抗原特异性γ干扰素(IFN-γ)水平高于PPD和CFP-10-ESAT-6。对C57BL/6小鼠进行免疫后,结果表明,与PPD和CFP-10-ESAT-6相比,用CFP-10-ESAT-6-PPE68'免疫的小鼠的总IgG滴度和IFN-γ浓度较高,并诱导了强烈、持久的体液免疫。因此,我们的研究表明,融合蛋白CFP-10-ESAT-6-PPE68'可能作为活动性TB血清诊断的免疫显性抗原。